CareGlance Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
10
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$4.07M
- Investors
-
4
CareGlance General Information
Description
Developer of an optical coherence tomography system designed to make a portable laser imaging system. The company's system offers portable, real-time optical coherence tomography (OCT) imaging systems with high coherence and resolution, as well as an OCT micro module with monolithic and hybrid integrations, enabling healthcare and industrial markets to achieve precise and efficient imaging for non-invasive three-dimensional imaging of tissues, materials, and surfaces.
Contact Information
Website
www.careglance-srl.itCorporate Office
- Via G. Durando 39
- 20158 Milan
- Italy
Corporate Office
- Via G. Durando 39
- 20158 Milan
- Italy
CareGlance Timeline
CareGlance Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC | 16-Dec-2025 | $4.07M | Completed | Generating Revenue | ||
| 5. Later Stage VC | 06-May-2024 | Completed | Generating Revenue | |||
| 4. Early Stage VC | 14-Jul-2023 | Completed | Generating Revenue | |||
| 3. Seed Round | 27-Jul-2022 | Completed | Startup | |||
| 2. Angel (individual) | 25-Jun-2021 | Completed | Startup | |||
| 1. Accelerator/Incubator | Completed | Startup |
CareGlance Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
CareGlance Patents
CareGlance Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4705718-A1 | Method and system for optical coherence tomography exploiting truncated singular value decomposition | Active | 03-May-2023 | ||
| EP-4705718-B1 | Method and system for optical coherence tomography exploiting truncated singular value decomposition | Active | 03-May-2023 | ||
| US-20260276365-A1 | Method and system for optical coherence tomography exploiting truncated singular value decomposition | Pending | 03-May-2023 | ||
| WO-2024228068-A1 | Method and system for optical coherence tomography exploiting truncated singular value decomposition | Inactive | 03-May-2023 | ||
| EP-4689543-A1 | Optical coherence tomography system for ranging applications | Active | 05-Apr-2023 | G01B9/02091 |
CareGlance Signals
CareGlance Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| CDP Venture Capital (Rome) | Venture Capital | Minority | ||
| EUREKA! Venture SGR | Venture Capital | Minority | ||
| LIFTT | Venture Capital | Minority | ||
| Polihub | Accelerator/Incubator |
CareGlance FAQs
-
When was CareGlance founded?
CareGlance was founded in 2019.
-
Where is CareGlance headquartered?
CareGlance is headquartered in Milan, Italy.
-
What is the size of CareGlance?
CareGlance has 10 total employees.
-
What industry is CareGlance in?
CareGlance’s primary industry is Diagnostic Equipment.
-
Is CareGlance a private or public company?
CareGlance is a Private company.
-
What is CareGlance’s current revenue?
The current revenue for CareGlance is .
-
How much funding has CareGlance raised over time?
CareGlance has raised $5.97M.
-
Who are CareGlance’s investors?
CDP Venture Capital (Rome), EUREKA! Venture SGR, LIFTT, and Polihub have invested in CareGlance.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process